Blue Jet Healthcare has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a final dividend of Rs 1.2 per share (60% of face value) for the fiscal year. Furthermore, the Board has approved a proposal to raise up to Rs 10,000 million through various financial instruments to support its growth strategies and capital requirements.
Financial Performance for FY2026
For the financial year ended March 31, 2026, Blue Jet Healthcare reported a total income of Rs 10,159.75 million. The company achieved a profit for the year of Rs 2,478.16 million. Specifically, for the fourth quarter (Jan-Mar 2026), the company recorded a profit of Rs 643.44 million on a total income of Rs 2,575.88 million. The company’s earnings per share (EPS) stood at Rs 14.29 for the full financial year.
Dividend Announcement
Reflecting the company’s strong financial standing, the Board of Directors has recommended a final dividend of Rs 1.2 per share, representing a 60% payout on the face value of Rs 2 per share. This recommendation is subject to the approval of shareholders at the upcoming Annual General Meeting.
Strategic Capital Expansion
To bolster its financial position and support expansion, the company has approved a proposal to raise up to Rs 10,000 million. This capital raise is planned through the issuance of various instruments, including equity shares, convertible debentures, or other equity-linked securities. These funds may be raised via qualified institutions placements (QIP), preferential issues, or private placements, subject to necessary regulatory and shareholder approvals.
Corporate Updates
The company also confirmed the re-appointment of M/s H.H. Chimthanawala & Co as the Internal Auditor for the 2026-27 financial year. Additionally, an Extra-Ordinary General Meeting is scheduled for June 17, 2026, to be conducted via video conferencing to discuss the proposed fund-raising initiatives.
Source: BSE
